Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.27 USD | +2.62% | +3.81% | -8.20% |
16/05 | AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft | MT |
02/05 | Transcript : AxoGen, Inc., Q1 2024 Earnings Call, May 02, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AXOGEN, INC. | Other Advanced Medical Equipment & Technology | +2.62% | +3.81% | -8.20% | -29.63% | -70.60% | 274M |
- Stock Market
- Equities
- AXGN Stock
- Charts AxoGen, Inc.
- Relative Strength Chart